Navigation Links
Gentiva® Health Services to Present at Upcoming Investor Conferences
Date:3/9/2011

ATLANTA, March 9, 2011 /PRNewswire/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV) announced today that it will present at the Barclays Capital 2011 Global Healthcare Conference in Miami, Florida at 3:15 p.m. ET on Tuesday, March 15, 2011 and at the Barclays Capital High Yield Bond and Syndicated Loan Conference in Orlando, Florida at 2:05 p.m. ET on Thursday, March 24, 2011.

The presentations will be available to the public via live audio webcasts, which may be accessed by visiting http://investors.gentiva.com/events.cfm. Visitors to this site will also be able to request advance notifications of these or other upcoming Gentiva events.

Gentiva executives will give attendees an overview of Gentiva's operations and strategic priorities, and review opportunities for growth as the United States home health and hospice industries provide more services to an aging population.

About Gentiva Health Services, Inc.Gentiva Health Services, Inc. is the nation's largest provider of home health and hospice services based on revenue, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. In August 2010, Gentiva acquired Odyssey HealthCare, Inc., one of the leading providers of hospice care in the United States. GTIV-G

Forward-Looking StatementCertain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of recently passed healthcare reform legislation and its subsequent implementation through governmental regulations; changes in Medicare, Medicaid and commercial payer reimbursement levels; the outcome of any inquiries into the Company's operations and business practices by governmental authorities; the Company's ability to effectively integrate Odyssey's operations; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010, as supplemented in the Company's quarterly report on Form 10-Q for the third quarter ended October 3, 2010. Financial and Investor Contact:Eric Slusser 770-951-6101eric.slusser@gentiva.comor John Mongelli770-221-6700john.mongelli@gentiva.comMedia Contact:Scott CianciulliBrainerd Communicators212-986-6667cianciulli@braincomm.com
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences
2. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
3. Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism
4. Endo to Present at the Barclays Capital 2011 GlobalHealthcare Conference
5. Isis Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
6. CVS/pharmacy Debuts the To Your Health Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community
7. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
8. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
9. Watson to Present at the Barclays 2011 Global Healthcare Conference
10. BioMarin to Present at the Barclays Global Healthcare Conference
11. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch ... gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial planning services from offices headquartered in Hamilton County, is embarking on ... LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... ... 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more ... a multi-function, sealed, LED luminaire that meets the needs of everyone in the patient ... , A 2’ x 4’ model features four modes: reading, ambient, standard ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
Breaking Medicine News(10 mins):